Bevel secures $10M Series A funding from General Catalyst as the AI health companion reaches 100,000 daily users with 8x growth, offering $6 monthly software that unifies wearable data across sleep, fitness, and nutrition without requiring proprietary hardware.
Capital Rx secures $400 million in funding and rebrands as Judi Health, accelerating its AI-powered platform that unifies pharmacy, medical, dental, and vision benefits for enterprise clients.
Yandex unveils groundbreaking open-source AI that detects cerebral palsy in infants under 12 months with 90% accuracy by analyzing MRI scans, reducing diagnosis time from days to minutes and offering free access to healthcare institutions worldwide through GitHub.
Google DeepMind releases AlphaMissense, a breakthrough AI system that predicts disease risk from 71 million genetic mutations with 90% accuracy, vastly outperforming existing methods and offering free access to researchers worldwide to accelerate rare disease diagnosis and treatment development.
Google launches DeepSomatic, an open-source AI tool that outperforms existing methods in identifying cancer-driving genetic variants, using advanced neural networks to distinguish inherited from acquired mutations and promising more precise cancer treatments for patients worldwide.
Google's new 27 billion parameter AI model discovers that combining silmitasertib with low-dose interferon can convert immune-resistant 'cold' tumors into 'hot' targets for immunotherapy, with lab tests confirming a 50% boost in immune recognition.
Salesforce and Anthropic expand their partnership to deliver Claude AI models through the Agentforce 360 Platform specifically for regulated industries like financial services and healthcare, making Anthropic the first AI provider fully integrated within Salesforce's secure virtual private cloud environment.
Stanford researchers unveil OpenTSLM, a groundbreaking AI model that crushes GPT-4o in medical analysis by 350%, achieving 92.9% accuracy in ECG interpretations while using 60% less computing power and providing human-readable explanations for complex medical time-series data.
MIT and McMaster University researchers use AI to discover enterololin, a revolutionary narrow-spectrum antibiotic that targets harmful gut bacteria causing Crohn's disease while preserving beneficial microbes, showing promising results in mouse studies and advancing toward human trials.
Stanford and Arc Institute scientists successfully use AI to design 16 functional viruses from scratch that infected bacteria and outcompeted natural viruses, marking the first time artificial intelligence has created entire living genomes rather than editing existing DNA, potentially revolutionizing treatments for antibiotic-resistant infections while raising safety concerns.